Functional Alterations in Cerebellar Functional Connectivity in Anxiety Disorders.

"Conflict of Interest Over the past 3 years, Dr. Pizzagalli has received consulting fees from Akili Interactive Labs, BlackThorn Therapeutics, Boehringer Ingelheim, Compass Pathway, Otsuka Pharmaceuticals, and Takeda Pharmaceuticals; one honorarium from Alkermes; and research funding from NIMH, Dana Foundation, Brain and Behavior Research Foundation, Millennium Pharmaceuticals. In addition, he has received stock options from BlackThorn Therapeutics."

"Funding This project was supported by the National Institute of Mental Health, U01MH108168 (JDEG, SWG), and F32MH114525 (NAH). NAH was partially supported by the Brain and Behavior Research Foundation. AY was partially supported by R01EB021265 and U01EB026996. DAP was partially supported by R37MH068376 and R01MH101521. RPA was partially supported by R01MH119771 and R56MH121426. SSG was partially supported by R01EB020740 and P41EB019936. SGH was partly supported by R01AT007257, R01MH099021, and the James S. McDonnell Foundation. This project was made possible by the resources provided by Shared Instrumentation Grants 1S10RR023401, 1S10RR019307, and 1S10RR023043."